404
Page Not Found
The page you're looking for doesn't exist or has been moved.
The page you're looking for doesn't exist or has been moved.
Trimi Medical Review Team
Clinical review workflow for GLP-1 safety, dosing, and access content
Team-based medical review process documented in Trimi's Medical Review Policy
Last reviewed: April 3, 2026
Medical Writers & Healthcare Professionals
Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.
Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.
Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.
Weight loss plateaus on GLP-1 medications are normal — STEP and SURMOUNT data shows most occur around week 68. Here's what to do when your medication seems to stop working.
After reaching your weight loss goal, what dose should you maintain? Learn about dose reduction strategies and minimum effective doses.
STEP trials show average 15% body weight loss over 68 weeks. Learn the week-by-week timeline, dose-response data, and factors that determine your results.
Detailed comparison of retatrutide vs orforglipron: injectable triple agonist vs the first oral GLP-1 pill. Weight loss data, convenience, side effects, and which might be right for you.